-5%
Esomeprazole, a proton pump inhibitor (PPI), reduces gastric acid production by inhibiting the H+/K+-ATPase enzyme in gastric parietal cells. It is the S-isomer of omeprazole, offering superior acid control compared to racemic PPIs.
- Absorption: Esomeprazole capsules are enteric-coated. Peak plasma levels occur approximately 1.5 hours after oral administration. Dose proportionality is observed, with a threefold increase in plasma concentration as dosage increases.

NexCap is prescribed for:
- Relief from chronic heartburn and other symptoms of GERD.
- Healing and maintenance of erosive esophagitis.
- Combination therapy with amoxicillin and clarithromycin for Helicobacter pylori eradication in duodenal ulcer patients.
- Zollinger-Ellison syndrome.
- Acid-related dyspepsia.
- Duodenal and gastric ulcers.
Use medication only as advised by a registered physician
